Cargando…
Complete remission with immunotherapy: Case report of a patient with metastatic bladder cancer to the humerus
Bladder cancer is the sixth most common malignancy in the United States. Cisplatin combination regimens are first line therapy for patients with metastatic urothelial bladder cancer who are eligible candidates and no treatments have shown to improve outcome compared to chemotherapy for the past 20 y...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036445/ https://www.ncbi.nlm.nih.gov/pubmed/32123665 http://dx.doi.org/10.1016/j.eucr.2020.101130 |